Corneal Cross-Linking: Evaluating the Potential for a Lower Power, Shorter Duration Treatment

Ciro Caruso1, Gaetano Barbaro, Robert L Epstein

  • 1*Corneal Transplant Center, Pellegrini Hospital, Naples, Italy;†I.R.O.S. (Institute of Refractive and Ophthalmic Surgery), Naples, Italy;‡Mercy Center for Corrective Eye Surgery, McHenry, IL;§Department of Pharmacy, University of Salerno, Fisciano, Salerno, Italy;¶Department of Pharmacy, University of Naples Federico II, Naples, Italy;‖Department of Ophthalmology, Pellegrini Hospital, Naples, Italy;**Eye Clinic, University of Naples Federico II, Naples, Italy; and††Department of Ophthalmology, Salerno University Hospital, Salerno, Italy.

Cornea
|March 19, 2016
PubMed
Summary

A new riboflavin ultraviolet-A (UV-A) corneal cross-linking treatment, shorter and lower energy than the Dresden protocol, significantly increased corneal stiffness. This accelerated protocol shows promise for corneal cross-linking applications.